Fundraising Fox

ValenTx

Maple Grove, US · Delaware corporation · 2 known investors

valentx.com ↗
Biotech

Founders & leadership

ML
MARY LINCOLN CAMPBELLDirector
MD
MITCHELL DANNDirector
JP
JON PATRICK ST. GERMAINExecutive Officer
DK
DAVID KRENNExecutive Officer
PA
PAUL A. LAVIOLETTEDirector
JN
JOHANN NEISZExecutive Officer, Director
BI
BOBBY I. GRIFFINDirector

Investors · 2

Kaiser Permanente VenturesSan Francisco · $2M – $5M
SV Health InvestorsBoston · $1M – $20Mvia Paul LaViolette · board

Reported raises · per SEC filings

Form D private placements
▶$2MraisedFeb 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elling HalvorsonDirector
  • Paul LaVioletteDirector
  • Bobby GriffinDirector
  • Jack AhrensDirector
  • Jon St. GermainExecutive Officer, Director
Offering amount
$5.3M
Amount sold
$2M
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.3MraisedAug 2018 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul LaVioletteDirector
  • Bobby I. GriffinDirector
  • Jon St. GermainExecutive Officer, Director
Amount sold
$10.3M
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedSep 2015 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARY LINCOLN CAMPBELLDirector
  • MITCHELL DANNDirector
  • JON PATRICK ST. GERMAINExecutive Officer
  • DAVID KRENNExecutive Officer
  • PAUL A. LAVIOLETTEDirector
  • JOHANN NEISZExecutive Officer, Director
  • BOBBY I. GRIFFINDirector
Offering amount
$7.5M
Amount sold
$7.5M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.